Filing Flows

Filing Flows › Companies › CVS Health › Timeline

CVS Health stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+9.9% to $83.85

CVS Health (CVS) stock rose 10% over the last 252 sessions, to $83.85. On the way it reported 4 quarters, its insiders filed 1 open-market trade, and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.

CVS: a year of the stock with every disclosure on itCVS: a year of the stock with every disclosure on it$77.06$88.83$101$112●2026-02-10 · Earnings: beat the EPS estimate by 9.4%◆2026-03-19 · Directors and officers: departures, appointments, pay●2026-05-06 · Earnings: beat the EPS estimate by 16.5%◆2026-05-18 · Directors and officers: departures, appointments, pay●2026-08-05 · Earnings: beat the EPS estimate by 39.4%◆2026-08-17 · Directors and officers: departures, appointments, pay●2026-11-04 · Earnings: beat the EPS estimate by 26.6%▲2026-11-06 · Shah Prem S bought $2.0M●Earnings report◆8-K event▲Insider buy2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 6, 2026Insider buyShah Prem S bought $2.0M+3.0% (+2.7% vs SPY)——
Nov 4, 2026EarningsEarnings: beat the EPS estimate by 26.6%−13.4% (−15.0% vs SPY)——
Aug 17, 20268-KDirectors and officers: departures, appointments, pay+1.0% (+1.6% vs SPY)+0.1% (+1.3% vs SPY)−2.5% (0.0% vs SPY)
Aug 5, 2026EarningsEarnings: beat the EPS estimate by 39.4%−5.2% (−5.0% vs SPY)−11.0% (−10.9% vs SPY)−7.1% (−6.3% vs SPY)
May 18, 20268-KDirectors and officers: departures, appointments, pay−1.9% (−1.2% vs SPY)−5.6% (−7.2% vs SPY)+3.3% (+2.9% vs SPY)
May 6, 2026EarningsEarnings: beat the EPS estimate by 16.5%+7.4% (+6.0% vs SPY)+16.5% (+14.5% vs SPY)+16.1% (+11.6% vs SPY)
Mar 19, 20268-KDirectors and officers: departures, appointments, pay−0.5% (+0.9% vs SPY)−1.0% (+1.0% vs SPY)+6.3% (−1.1% vs SPY)
Feb 10, 2026EarningsEarnings: beat the EPS estimate by 9.4%−0.1% (+0.2% vs SPY)+3.2% (+4.8% vs SPY)−0.1% (+2.5% vs SPY)

Insiders’ record here

In the year on the chart, CVS Health's insiders reported 1 open-market buy ($2.0M) and 0 sales ($0).

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → CVS Health: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.